Literature DB >> 7741574

Randomised trial spacer v nebuliser for acute asthma.

P C Parkin1, N R Saunders, S A Diamond, P M Winders, C Macarthur.   

Abstract

Sixty hospitalised children with asthma aged 1-5 years were randomised to spacer or nebuliser. A clinical score was measured at baseline and every 12 hours. There were no differences between groups in the score over time, or secondary outcome measures. The spacer is an effective delivery method for young hospitalised asthmatic children.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7741574      PMCID： PMC1511081          DOI： 10.1136/adc.72.3.239

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  6 in total

1.  Substitution of metered-dose inhalers for hand-held nebulizers. Success and cost savings in a large, acute-care hospital.

Authors:  D L Bowton; W M Goldsmith; E F Haponik
Journal:  Chest       Date:  1992-02       Impact factor: 9.410

2.  Spacer device with face mask attachment for giving bronchodilators to infants with asthma.

Authors:  C O'Callaghan; A D Milner; A Swarbrick
Journal:  BMJ       Date:  1989-01-21

3.  Efficacy of albuterol administered by nebulizer versus spacer device in children with acute asthma.

Authors:  E Kerem; H Levison; S Schuh; H O'Brodovich; J Reisman; L Bentur; G J Canny
Journal:  J Pediatr       Date:  1993-08       Impact factor: 4.406

4.  Ipratropium bromide delivered by metered-dose aerosol to infant wheezers.

Authors:  A G Wesley; F Paruk; M H Broughton; E Gouws
Journal:  S Afr Med J       Date:  1991-05-04

5.  Reliable salbutamol administration in 6- to 36-month-old children by means of a metered dose inhaler and Aerochamber with mask.

Authors:  W T Conner; M B Dolovich; R A Frame; M T Newhouse
Journal:  Pediatr Pulmonol       Date:  1989

6.  Albuterol delivered via metered-dose inhaler with spacer for outpatient treatment of young children with wheezing.

Authors:  R W Hickey; R F Gochman; V Chande; H W Davis
Journal:  Arch Pediatr Adolesc Med       Date:  1994-02
  6 in total
  11 in total

Review 1.  Pharmacologic management of the hospitalized pediatric asthma patient.

Authors:  K A Hardin; H J Kallas; R J McDonald
Journal:  Clin Rev Allergy Immunol       Date:  2001-06       Impact factor: 8.667

2.  Relative bioavailability of salbutamol to the lung following inhalation when administration is prolonged.

Authors:  V L Silkstone; H S Tomlinson; S A Corlett; H Chrystyn
Journal:  Br J Clin Pharmacol       Date:  2000-09       Impact factor: 4.335

Review 3.  The economic aspects of drug delivery in asthma.

Authors:  R J Massie; C M Mellis
Journal:  Pharmacoeconomics       Date:  1997-05       Impact factor: 4.981

Review 4.  Nebuliser therapy in childhood.

Authors:  P W Barry; C O'Callaghan
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

Review 5.  Management of children with severe asthma exacerbation in the emergency department.

Authors:  Benjamin Volovitz; Moshe Nussinovitch
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 6.  Antiasthmatic drug delivery in children.

Authors:  Elizabeth Biggart; Andrew Bush
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

7.  A randomised controlled trial to assess the relative benefits of large volume spacers and nebulisers to treat acute asthma in hospital.

Authors:  A L Dewar; A Stewart; J J Cogswell; G J Connett
Journal:  Arch Dis Child       Date:  1999-05       Impact factor: 3.791

Review 8.  Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma.

Authors:  Christopher J Cates; Emma J Welsh; Brian H Rowe
Journal:  Cochrane Database Syst Rev       Date:  2013-09-13

9.  Scintigraphic Assessment of Deposition of Radiolabeled Fluticasone Delivered from a Nebulizer and Metered Dose Inhaler in 10 Healthy Dogs.

Authors:  K E Chow; D Tyrrell; M Yang; L A Abraham; G A Anderson; C S Mansfield
Journal:  J Vet Intern Med       Date:  2017-09-29       Impact factor: 3.333

10.  Replacing nebulizers by MDI-spacers for bronchodilator and inhaled corticosteroid administration: Impact on the utilization of hospital resources.

Authors:  S A Alhaider; H A Alshehri; K Al-Eid
Journal:  Int J Pediatr Adolesc Med       Date:  2014-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.